2017 PEDIATRIC ONCOLOGY GROUP OF ONTARIO (POGO) MULTI-DISCIPLINARY SYMPOSIUM ON CHILDHOOD CANCER
Westin Prince HotelTORONTO, USA Visit the Venue to read more
The 2017 POGO Multi-Disciplinary Symposium on Childhood Cancer – Cancer in Infancy: Tiny Patients, Huge Challenges – will examine clinical and scientific advances in cancer in infancy and the associated physical, psychosocial and medical issues, as well as focus on relevant resources, tools and strategies for a multidisciplinary audience.
Pediatric oncologists, nurses, social workers, and other health care professionals will enhance their knowledge of cancer in infancy through a series of plenary lectures, interactive workshops, poster presentations and display, and ‘meet-the-expert’ sessions. The teaching faculty include nationally and internationally recognized experts across a broad range of disciplines. The overarching goal will be for participants to be able to apply what they have learned to their day-to-day practice of pediatric oncology as it applies to infants with cancer, as well as to generate novel questions to be explored in a research setting within their respective disciplines
Recognize the core principles necessary for effective identification, monitoring and management of pain in infants, particularly relevant in the context of disease or treatment-related pain in the infant with cancer.
Describe the clinical and genetic features of hereditary and sporadic retinoblastoma, and discuss the evolution of therapy for this disease that has occurred over the last 40 years. Participants will be able to discuss the different approaches that have been taken to manage this disease, reflecting on the use of surgery, systemic and local chemotherapy, radiation and laser therapy.
Identify the spectrum of malignant and benign tumours that can present prenatally, and describe the indications for fetal surgical intervention along with the potential benefits and complications.
Categorize the molecular and immunophenotypes of different forms of infant leukemia and apply this knowledge to defining prognostic implications and rationale for particular therapeutic opportunities through clinical trials.
Recognize the signs and symptoms associated with infant brain tumours, describe the common tumour types that occur in this age group, and discuss the major challenges in design and implementation of treatment plans to balance improved survival while mitigating short- and long-term toxicities.
Define the developmental milestones that must be monitored in infants with cancer and recognize when these milestones are not being achieved. The participants will also be able to know what instruments can be applied to measure developmental, psychosocial, and behavioural patterns in a longitudinal manner during and after the infant’s treatment.
Know the signs and symptoms associated with presentation of infants with neuroblastoma and describe the molecular, clinical and pathologic tests required to appropriately classify the disease. The participants will also be able to apply this information to develop an appropriate therapy plan, and be able to discuss emerging novel treatment options.
Recognize behavioural and psychosocial patterns in parents and siblings of infants with cancer, as well as learn of coping mechanisms that can be applied to alleviate parent/sibling stress that develops as a result of both the diagnosis and treatment of the infant.
Describe different methods to maintain a good nutritional balance in infants with cancer and to apply methods to overcome challenges associated with poor nutritional intake as a result of therapy or the disease itself.
Recognize the unique infectious complications in infants with cancer related to commensal organisms, as well as to be able to articulate the new guidelines for blood product screening, particularly with respect to cytomegalovirus and other potential pathogen contamination.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
POGO has reserved a block of guest rooms at the Westin Prince Hotel for Symposium delegates. The rate is $169.00 + 13% HST + 3% DMP per room per night. This rate is guaranteed until Monday, October 9, 2017.
To reserve a room, simply call 1-888-627-8550 and quote: “Pediatric Oncology Group of Ontario“
By Public Transportation
From Toronto Union Station
Take Yonge line north to York Mills station
Catch 95C bus heading east towards Ellesmere Station
Get off at Upjohn Road; hotel is a 2-minute walk from this point
Abstracts are encouraged in all areas related to care and control of malignant disease in children. Submissions may cover ANY dimension of childhood cancer care and control including research, innovative program delivery, data management, and education and policy development. All professional disciplines are encouraged to submit posters.
Abstracts must be submitted by Monday, September 18, 2017. Accepted abstracts will appear in the Abstract Booklet provided to all delegates at the Symposium.
Read the Abstract Submission Guide to familiarize yourself with formatting requirements, word count, see a sample abstract, etc. Abstracts that do not follow the formatting specifications contained in this guide will not be accepted.
Abstract submission deadline 2017-09-18
POGO will award $250.00 for one outstanding abstract submitted by a Fellow/Trainee in each of the following categories:
Phone: 855-367-7646 or 416-592-1232
Phone: 855-367-7646 or 416-592-1232